CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Conditions
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Chronic Myeloid Leukemia, BCR-ABL1 Positive
- Hematopoietic and Lymphoid System Neoplasm
- Hodgkin Lymphoma
- Myelodysplastic Syndrome
- Myelofibrosis
- Myeloproliferative Neoplasm
- Non-Hodgkin Lymphoma
Interventions
- PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
- PROCEDURE: Biospecimen Collection
- DRUG: Granulocyte Colony-Stimulating Factor
- DRUG: Hematopoietic Cell Transplantation Conditioning Regimen
- BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
- PROCEDURE: Pheresis
- DRUG: Placebo Administration
- DRUG: Stem Cell Mobilization Therapy
Sponsor
City of Hope Medical Center
Collaborators